• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CXS
Click for more information
0.00% 70.0¢

CHEMGENEX PHARMACEUTICALS LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CXSAppendix 3B28/10/10 download Created with Sketch. 119.05KB
CXSNotice of Annual General Meeting/Proxy Form22/10/10 download Created with Sketch. 126.68KB
CXSAnnual Report to shareholders22/10/10 download Created with Sketch. 1.04MB
CXSChange of Director's Interest Notice22/10/10 download Created with Sketch. 21.38KB
CXSChange of Director's Interest Notice22/10/10 download Created with Sketch. 21.49KB
CXSBecoming a substantial holder22/10/10 download Created with Sketch. 847.24KB
CXSConvertible Note Issued to Cephalon, IncPRICE SENSITIVE22/10/10 download Created with Sketch. 190.64KB
CXSAppendix 3B15/10/10 download Created with Sketch. 114.06KB
CXSResponse to an ASX Price QueryPRICE SENSITIVE05/10/10 download Created with Sketch. 213.31KB
CXSChemGenex Completes pre-NDA Meeting with U.S. FDAPRICE SENSITIVE05/10/10 download Created with Sketch. 149.61KB
CXSPresentation at International Investment Conference13/09/10 download Created with Sketch. 1.31MB
CXSAppendix 3B06/09/10 download Created with Sketch. 113.98KB
CXSPreliminary Final ReportPRICE SENSITIVE27/08/10 download Created with Sketch. 375.82KB
CXSAppendix 3B09/08/10 download Created with Sketch. 115.71KB
CXSAppendix 3B02/08/10 download Created with Sketch. 113.95KB
CXSFDA agrees on potential regulatory pathway for OMAPROPRICE SENSITIVE14/07/10 download Created with Sketch. 1.35MB
CXSChange of Director's Interest Notice28/06/10 download Created with Sketch. 20.71KB
CXSAppendix 3B28/06/10 download Created with Sketch. 113.96KB
CXSChange in substantial holding17/06/10 download Created with Sketch. 79.53KB
CXSAppendix 3B15/06/10 download Created with Sketch. 179.61KB
CXSAnnounces updated OMAPRO safety data at ASCO07/06/10 download Created with Sketch. 115.65KB
CXSAppendix 3B12/05/10 download Created with Sketch. 66.67KB
CXSInvestor Update04/05/10 download Created with Sketch. 569.11KB
CXSComplete Response Letter from FDA ReceivedPRICE SENSITIVE12/04/10 download Created with Sketch. 29.25KB
CXSChange of Director's Interest Notice29/03/10 download Created with Sketch. 107.81KB
CXSAppendix 3B29/03/10 download Created with Sketch. 162.74KB
CXSAppendix 3B29/03/10 download Created with Sketch. 164.39KB
CXSChange in substantial holding26/03/10 download Created with Sketch. 76.59KB
CXSChange in substantial holding25/03/10 download Created with Sketch. 81.07KB
CXSODAC seeks validated diganostic before approval of OMAPROPRICE SENSITIVE23/03/10 download Created with Sketch. 113.69KB
CXSAppendix 3B18/03/10 download Created with Sketch. 66.91KB
CXSChange of Director's Interest Notice16/03/10 download Created with Sketch. 107.88KB
CXSAppendix 3B16/03/10 download Created with Sketch. 66.6KB
CXSAppendix 3B15/03/10 download Created with Sketch. 67.81KB
CXSAppendix 3B15/03/10 download Created with Sketch. 68.26KB
CXSAppendix 3B04/03/10 download Created with Sketch. 175.66KB
CXSODAC Meeting Rescheduled to 22 March 201002/03/10 download Created with Sketch. 99.43KB
CXSHalf Yearly Report and AccountsPRICE SENSITIVE25/02/10 download Created with Sketch. 411.88KB
CXSChange in substantial holding22/02/10 download Created with Sketch. 82.07KB
CXSChange of Director's Interest Notice11/02/10 download Created with Sketch. 21.86KB
CXSCXSO Option Expiry09/02/10 download Created with Sketch. 438.2KB
CXSODAC Postponed Due to Extreme Weather in Washington DCPRICE SENSITIVE09/02/10 download Created with Sketch. 37.54KB
CXSAppendix 3B29/01/10 download Created with Sketch. 68.05KB
CXSAppendix 3B20/01/10 download Created with Sketch. 82.43KB
CXSAppendix 3B06/01/10 download Created with Sketch. 68.44KB
CXSChange in substantial holding31/12/09 download Created with Sketch. 82.46KB
CXSDetails of Share Registry address17/12/09 download Created with Sketch. 23.2KB
CXSAppendix 3B17/12/09 download Created with Sketch. 68.38KB
CXSOmapro ODAC meeting confirmed for 10 February 2010PRICE SENSITIVE17/12/09 download Created with Sketch. 37.87KB
CXSInvestor Briefing - Teleconference/Webcast14/12/09 download Created with Sketch. 28.29KB
CXSOmacetaxine European rights licensed to HospiraPRICE SENSITIVE14/12/09 download Created with Sketch. 42.85KB
CXSUpdated omacetaxine data from multiTKI failure studyPRICE SENSITIVE09/12/09 download Created with Sketch. 46.97KB
CXSOmapro Data Highlighted at ASH Press ConferencePRICE SENSITIVE07/12/09 download Created with Sketch. 50.61KB
CXSChange of Director's Interest Notice03/12/09 download Created with Sketch. 20.67KB
CXSAppendix 3B01/12/09 download Created with Sketch. 68.05KB
CXSPresentation of Data at Annual ASH Meeting01/12/09 download Created with Sketch. 42.37KB
CXSAppendix 3B30/11/09 download Created with Sketch. 69.29KB
CXSResults of Meeting30/11/09 download Created with Sketch. 38.31KB
CXSChairman's Address to Shareholders30/11/09 download Created with Sketch. 22.53KB
CXSCEO's Presentation AGM 200930/11/09 download Created with Sketch. 618.44KB
CXSEMEA validates ChemGenex's MAA for omacetaxinePRICE SENSITIVE27/11/09 download Created with Sketch. 42.05KB
CXSUS FDA accepts Omapro NDA - grants priority reviewPRICE SENSITIVE10/11/09 download Created with Sketch. 41.66KB
CXSAppendix 3B02/11/09 download Created with Sketch. 49.31KB
CXSAnnual Report to shareholders28/10/09 download Created with Sketch. 831.52KB
CXSNotice of Annual General Meeting/Proxy Form28/10/09 download Created with Sketch. 148.61KB
CXSCEO Receives AusBiotech Award28/10/09 download Created with Sketch. 49.86KB
CXSCorporate presentation September 200910/09/09 download Created with Sketch. 325.93KB
CXSPresentation at International Investment Conference09/09/09 download Created with Sketch. 33.01KB
CXSSubmits New Drug Application for Omacetaxine to FDA09/09/09 download Created with Sketch. 42.04KB
CXSPreliminary Final ReportPRICE SENSITIVE27/08/09 download Created with Sketch. 341.27KB
CXSDetails of Share Registry address19/08/09 download Created with Sketch. 37.11KB
CXSAppendix 3B10/08/09 download Created with Sketch. 49.79KB
CXSDirector Appointment/Resignation21/07/09 download Created with Sketch. 61.16KB
CXSAppointment of Chief Commercial Officer20/07/09 download Created with Sketch. 40.65KB
CXSAppendix 3B07/07/09 download Created with Sketch. 49.09KB
CXSChemGenex to de-list from NASDAQ and restructure Board29/06/09 download Created with Sketch. 40.86KB
CXSAppendix 3B25/06/09 download Created with Sketch. 49.17KB
CXSResponse to an ASX Query - Director's Interest Notice24/06/09 download Created with Sketch. 163.83KB
CXSChange in substantial holding17/06/09 download Created with Sketch. 119.48KB
CXSChange of Director's Interest Notice12/06/09 download Created with Sketch. 22.14KB
CXSChange of Director's Interest Notice12/06/09 download Created with Sketch. 22.12KB
CXSChange of Director's Interest Notice12/06/09 download Created with Sketch. 22.07KB
CXSInvestor Update11/06/09 download Created with Sketch. 255.25KB
CXSInvestor briefing teleconference/webcast10/06/09 download Created with Sketch. 37.24KB
CXSOmacetaxine Kills Leukemic Stem Cells in Human CML ModelsPRICE SENSITIVE09/06/09 download Created with Sketch. 39.58KB
CXSOmacetaxine Shows Activity in Refractory CMLPRICE SENSITIVE09/06/09 download Created with Sketch. 45.64KB
CXSOmacetaxine Clinical Data Presented at ASCOPRICE SENSITIVE02/06/09 download Created with Sketch. 45.34KB
CXSChange in substantial holding01/06/09 download Created with Sketch. 85.03KB
CXSDetails of Rights Issue Scale-Back29/05/09 download Created with Sketch. 39.56KB
CXSRights Issue Fully Subscribed, Further $1 Million PlacementPRICE SENSITIVE27/05/09 download Created with Sketch. 44.53KB
CXSs708A(5)(e) Disclosure Notice - Share issuance27/05/09 download Created with Sketch. 40.24KB
CXSAppendix 3B27/05/09 download Created with Sketch. 52.52KB
CXSOmacetaxine to be Showcased at EHA21/05/09 download Created with Sketch. 38.77KB
CXSRights Issue Entitlement Reminder15/05/09 download Created with Sketch. 39.27KB
CXSOmacetaxine Oral Presentation at ASCO15/05/09 download Created with Sketch. 38.13KB
CXSChange of Director's Interest Notice14/05/09 download Created with Sketch. 13.78KB
CXSInvestor Roadshow presentation11/05/09 download Created with Sketch. 184.11KB
CXSRights Issue Information sent to Shareholders04/05/09 download Created with Sketch. 22.31KB
CXSChange of Director's Interest Notice04/05/09 download Created with Sketch. 50.08KB
CXSCFO and Company Secretary Transition04/05/09 download Created with Sketch. 36.97KB
CXSAppendix 3B
28/10/10 download Created with Sketch. 119.05KB
CXSNotice of Annual General Meeting/Proxy Form
22/10/10 download Created with Sketch. 126.68KB
CXSAnnual Report to shareholders
22/10/10 download Created with Sketch. 1.04MB
CXSChange of Director's Interest Notice
22/10/10 download Created with Sketch. 21.38KB
CXSChange of Director's Interest Notice
22/10/10 download Created with Sketch. 21.49KB
CXSBecoming a substantial holder
22/10/10 download Created with Sketch. 847.24KB
CXSConvertible Note Issued to Cephalon, Inc
22/10/10PRICE SENSITIVE download Created with Sketch. 190.64KB
CXSAppendix 3B
15/10/10 download Created with Sketch. 114.06KB
CXSResponse to an ASX Price Query
05/10/10PRICE SENSITIVE download Created with Sketch. 213.31KB
CXSChemGenex Completes pre-NDA Meeting with U.S. FDA
05/10/10PRICE SENSITIVE download Created with Sketch. 149.61KB
CXSPresentation at International Investment Conference
13/09/10 download Created with Sketch. 1.31MB
CXSAppendix 3B
06/09/10 download Created with Sketch. 113.98KB
CXSPreliminary Final Report
27/08/10PRICE SENSITIVE download Created with Sketch. 375.82KB
CXSAppendix 3B
09/08/10 download Created with Sketch. 115.71KB
CXSAppendix 3B
02/08/10 download Created with Sketch. 113.95KB
CXSFDA agrees on potential regulatory pathway for OMAPRO
14/07/10PRICE SENSITIVE download Created with Sketch. 1.35MB
CXSChange of Director's Interest Notice
28/06/10 download Created with Sketch. 20.71KB
CXSAppendix 3B
28/06/10 download Created with Sketch. 113.96KB
CXSChange in substantial holding
17/06/10 download Created with Sketch. 79.53KB
CXSAppendix 3B
15/06/10 download Created with Sketch. 179.61KB
CXSAnnounces updated OMAPRO safety data at ASCO
07/06/10 download Created with Sketch. 115.65KB
CXSAppendix 3B
12/05/10 download Created with Sketch. 66.67KB
CXSInvestor Update
04/05/10 download Created with Sketch. 569.11KB
CXSComplete Response Letter from FDA Received
12/04/10PRICE SENSITIVE download Created with Sketch. 29.25KB
CXSChange of Director's Interest Notice
29/03/10 download Created with Sketch. 107.81KB
CXSAppendix 3B
29/03/10 download Created with Sketch. 162.74KB
CXSAppendix 3B
29/03/10 download Created with Sketch. 164.39KB
CXSChange in substantial holding
26/03/10 download Created with Sketch. 76.59KB
CXSChange in substantial holding
25/03/10 download Created with Sketch. 81.07KB
CXSODAC seeks validated diganostic before approval of OMAPRO
23/03/10PRICE SENSITIVE download Created with Sketch. 113.69KB
CXSAppendix 3B
18/03/10 download Created with Sketch. 66.91KB
CXSChange of Director's Interest Notice
16/03/10 download Created with Sketch. 107.88KB
CXSAppendix 3B
16/03/10 download Created with Sketch. 66.6KB
CXSAppendix 3B
15/03/10 download Created with Sketch. 67.81KB
CXSAppendix 3B
15/03/10 download Created with Sketch. 68.26KB
CXSAppendix 3B
04/03/10 download Created with Sketch. 175.66KB
CXSODAC Meeting Rescheduled to 22 March 2010
02/03/10 download Created with Sketch. 99.43KB
CXSHalf Yearly Report and Accounts
25/02/10PRICE SENSITIVE download Created with Sketch. 411.88KB
CXSChange in substantial holding
22/02/10 download Created with Sketch. 82.07KB
CXSChange of Director's Interest Notice
11/02/10 download Created with Sketch. 21.86KB
CXSCXSO Option Expiry
09/02/10 download Created with Sketch. 438.2KB
CXSODAC Postponed Due to Extreme Weather in Washington DC
09/02/10PRICE SENSITIVE download Created with Sketch. 37.54KB
CXSAppendix 3B
29/01/10 download Created with Sketch. 68.05KB
CXSAppendix 3B
20/01/10 download Created with Sketch. 82.43KB
CXSAppendix 3B
06/01/10 download Created with Sketch. 68.44KB
CXSChange in substantial holding
31/12/09 download Created with Sketch. 82.46KB
CXSDetails of Share Registry address
17/12/09 download Created with Sketch. 23.2KB
CXSAppendix 3B
17/12/09 download Created with Sketch. 68.38KB
CXSOmapro ODAC meeting confirmed for 10 February 2010
17/12/09PRICE SENSITIVE download Created with Sketch. 37.87KB
CXSInvestor Briefing - Teleconference/Webcast
14/12/09 download Created with Sketch. 28.29KB
CXSOmacetaxine European rights licensed to Hospira
14/12/09PRICE SENSITIVE download Created with Sketch. 42.85KB
CXSUpdated omacetaxine data from multiTKI failure study
09/12/09PRICE SENSITIVE download Created with Sketch. 46.97KB
CXSOmapro Data Highlighted at ASH Press Conference
07/12/09PRICE SENSITIVE download Created with Sketch. 50.61KB
CXSChange of Director's Interest Notice
03/12/09 download Created with Sketch. 20.67KB
CXSAppendix 3B
01/12/09 download Created with Sketch. 68.05KB
CXSPresentation of Data at Annual ASH Meeting
01/12/09 download Created with Sketch. 42.37KB
CXSAppendix 3B
30/11/09 download Created with Sketch. 69.29KB
CXSResults of Meeting
30/11/09 download Created with Sketch. 38.31KB
CXSChairman's Address to Shareholders
30/11/09 download Created with Sketch. 22.53KB
CXSCEO's Presentation AGM 2009
30/11/09 download Created with Sketch. 618.44KB
CXSEMEA validates ChemGenex's MAA for omacetaxine
27/11/09PRICE SENSITIVE download Created with Sketch. 42.05KB
CXSUS FDA accepts Omapro NDA - grants priority review
10/11/09PRICE SENSITIVE download Created with Sketch. 41.66KB
CXSAppendix 3B
02/11/09 download Created with Sketch. 49.31KB
CXSAnnual Report to shareholders
28/10/09 download Created with Sketch. 831.52KB
CXSNotice of Annual General Meeting/Proxy Form
28/10/09 download Created with Sketch. 148.61KB
CXSCEO Receives AusBiotech Award
28/10/09 download Created with Sketch. 49.86KB
CXSCorporate presentation September 2009
10/09/09 download Created with Sketch. 325.93KB
CXSPresentation at International Investment Conference
09/09/09 download Created with Sketch. 33.01KB
CXSSubmits New Drug Application for Omacetaxine to FDA
09/09/09 download Created with Sketch. 42.04KB
CXSPreliminary Final Report
27/08/09PRICE SENSITIVE download Created with Sketch. 341.27KB
CXSDetails of Share Registry address
19/08/09 download Created with Sketch. 37.11KB
CXSAppendix 3B
10/08/09 download Created with Sketch. 49.79KB
CXSDirector Appointment/Resignation
21/07/09 download Created with Sketch. 61.16KB
CXSAppointment of Chief Commercial Officer
20/07/09 download Created with Sketch. 40.65KB
CXSAppendix 3B
07/07/09 download Created with Sketch. 49.09KB
CXSChemGenex to de-list from NASDAQ and restructure Board
29/06/09 download Created with Sketch. 40.86KB
CXSAppendix 3B
25/06/09 download Created with Sketch. 49.17KB
CXSResponse to an ASX Query - Director's Interest Notice
24/06/09 download Created with Sketch. 163.83KB
CXSChange in substantial holding
17/06/09 download Created with Sketch. 119.48KB
CXSChange of Director's Interest Notice
12/06/09 download Created with Sketch. 22.14KB
CXSChange of Director's Interest Notice
12/06/09 download Created with Sketch. 22.12KB
CXSChange of Director's Interest Notice
12/06/09 download Created with Sketch. 22.07KB
CXSInvestor Update
11/06/09 download Created with Sketch. 255.25KB
CXSInvestor briefing teleconference/webcast
10/06/09 download Created with Sketch. 37.24KB
CXSOmacetaxine Kills Leukemic Stem Cells in Human CML Models
09/06/09PRICE SENSITIVE download Created with Sketch. 39.58KB
CXSOmacetaxine Shows Activity in Refractory CML
09/06/09PRICE SENSITIVE download Created with Sketch. 45.64KB
CXSOmacetaxine Clinical Data Presented at ASCO
02/06/09PRICE SENSITIVE download Created with Sketch. 45.34KB
CXSChange in substantial holding
01/06/09 download Created with Sketch. 85.03KB
CXSDetails of Rights Issue Scale-Back
29/05/09 download Created with Sketch. 39.56KB
CXSRights Issue Fully Subscribed, Further $1 Million Placement
27/05/09PRICE SENSITIVE download Created with Sketch. 44.53KB
CXSs708A(5)(e) Disclosure Notice - Share issuance
27/05/09 download Created with Sketch. 40.24KB
CXSAppendix 3B
27/05/09 download Created with Sketch. 52.52KB
CXSOmacetaxine to be Showcased at EHA
21/05/09 download Created with Sketch. 38.77KB
CXSRights Issue Entitlement Reminder
15/05/09 download Created with Sketch. 39.27KB
CXSOmacetaxine Oral Presentation at ASCO
15/05/09 download Created with Sketch. 38.13KB
CXSChange of Director's Interest Notice
14/05/09 download Created with Sketch. 13.78KB
CXSInvestor Roadshow presentation
11/05/09 download Created with Sketch. 184.11KB
CXSRights Issue Information sent to Shareholders
04/05/09 download Created with Sketch. 22.31KB
CXSChange of Director's Interest Notice
04/05/09 download Created with Sketch. 50.08KB
CXSCFO and Company Secretary Transition
04/05/09 download Created with Sketch. 36.97KB
refresh Created with Sketch. REFRESH
 

Top Stories

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

Nexus Minerals Ltd has completed diamond drilling at its Bethanga project in Victoria, picking up signs of a potential porphyry system.
Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring Sun Silver executive director Gerard O'Donovan discusses a 6,216 grams Fort Intercept at the Maverick Spring Silver Project from historical data and drill assessments.
ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus The Australian Bureau of Statistics (ABS) has released the latest Consumer Price Index (CPI) inflation data, showing local inflation has hit 4%.
Sheffield Resources achieves milestone production, shipments at Thunderbird, WA Sheffield Resources (ASX:SFX) has ramped up production and shipments from its Thunderbird Mineral Sands Mine in Western Australia. In June 2024, approximately 825,000 tonnes of ore were mined, with a quarterly expectation of 2.2 million tonnes, surpassing the 2022 Bankable Feasibility Study forecast by 20%.
Nimy extends sulphide targets at Mons with new anomalies identified Nimy Resources Ltd has reported successful results from its geophysics work at the Mons project in Western Australia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.